Cold plunge therapy sits in an interesting place in the recovery landscape. The evidence for short-term recovery benefits and ...

Cytokinetics announced FDA approval of MYQORZO™ (aficamten) to treat adults with symptomatic obstructive hypertrophic ...

In a decades-long effort, researchers have discovered how to tweak the molecular pathways that turn heart muscle motors up or down ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

From Hyrox to Pilates, resistance bands and even yoga, experts explain what actually builds muscles – and why it gets harder ...

Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

Cancer patients often lose excessive amounts of weight. This affects up to 80% of patients and is mainly due to a decrease in muscle mass and fatty tissue. This cancer-induced cachexia (CIC) is ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Hackensack Meridian JFK’s chief of cardiology explains how alcohol, salty foods, and holiday excess can lead to dangerous ...

While shoveling snow may seem like one more household chore, it can be hazardous – and sometimes fatal – to people with ...

Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart inflammation is a window into how powerful immune technologies sometimes misfire in ...

In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...